CHARLES SCHWAB INVESTMENT MANAGEMENT INC - USANA HEALTH SCIENCES INC ownership

USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 192 filers reported holding USANA HEALTH SCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of USANA HEALTH SCIENCES INC
ValueSharesWeighting
Q3 2023$12,535,917
-3.4%
213,887
+3.9%
0.00%0.0%
Q2 2023$12,973,822
+2.0%
205,803
+1.8%
0.00%0.0%
Q1 2023$12,714,481
+26.2%
202,138
+6.7%
0.00%
+33.3%
Q4 2022$10,078,048
+6.4%
189,437
+12.2%
0.00%0.0%
Q3 2022$9,468,000
-17.0%
168,898
+7.2%
0.00%
-25.0%
Q2 2022$11,405,000
+0.1%
157,614
+9.9%
0.00%
+33.3%
Q1 2022$11,394,000
-16.4%
143,402
+6.4%
0.00%
-25.0%
Q4 2021$13,637,000
+7.9%
134,748
-1.7%
0.00%0.0%
Q3 2021$12,638,000
-6.2%
137,059
+4.1%
0.00%0.0%
Q2 2021$13,480,000
+10.2%
131,600
+5.0%
0.00%0.0%
Q1 2021$12,235,000
+15.9%
125,349
-8.5%
0.00%0.0%
Q4 2020$10,557,000
+7.8%
136,924
+2.9%
0.00%
-20.0%
Q3 2020$9,797,000
-2.1%
133,015
-2.4%
0.01%0.0%
Q2 2020$10,010,000
+25.5%
136,314
-1.3%
0.01%0.0%
Q1 2020$7,975,000
-17.3%
138,061
+12.4%
0.01%0.0%
Q4 2019$9,647,000
+20.8%
122,812
+5.2%
0.01%0.0%
Q3 2019$7,984,000
-44.5%
116,733
-35.5%
0.01%
-44.4%
Q2 2019$14,375,000
-3.0%
180,971
+2.4%
0.01%0.0%
Q1 2019$14,822,000
-6.2%
176,717
+31.6%
0.01%
-25.0%
Q4 2018$15,809,000
-0.1%
134,281
+2.3%
0.01%
+9.1%
Q3 2018$15,828,000
+7.3%
131,298
+2.6%
0.01%0.0%
Q2 2018$14,750,000
+33.9%
127,919
-0.2%
0.01%
+22.2%
Q1 2018$11,012,000
+78.1%
128,191
+53.6%
0.01%
+80.0%
Q4 2017$6,182,000
+26.2%
83,484
-1.6%
0.01%
+25.0%
Q3 2017$4,897,000
-17.0%
84,857
-7.8%
0.00%
-33.3%
Q2 2017$5,902,000
-18.0%
92,061
-26.3%
0.01%
-14.3%
Q1 2017$7,198,000
-2.5%
124,961
+3.6%
0.01%
-12.5%
Q4 2016$7,385,000
+55.9%
120,664
+252.5%
0.01%
+33.3%
Q3 2016$4,737,000
+30.6%
34,233
+5.2%
0.01%
+20.0%
Q2 2016$3,627,000
-21.0%
32,543
-13.9%
0.01%
-16.7%
Q1 2016$4,591,000
-8.8%
37,806
-4.0%
0.01%
-14.3%
Q4 2015$5,033,000
-19.7%
39,391
-15.7%
0.01%
-22.2%
Q3 2015$6,265,000
+2.8%
46,738
+4.8%
0.01%
+12.5%
Q2 2015$6,096,000
+27.8%
44,605
+3.9%
0.01%
+14.3%
Q1 2015$4,769,000
+24.5%
42,913
+14.9%
0.01%
+16.7%
Q4 2014$3,832,000
+114.8%
37,352
+54.2%
0.01%
+100.0%
Q3 2014$1,784,000
+7.7%
24,219
+14.3%
0.00%0.0%
Q2 2014$1,656,000
+50.1%
21,180
+44.8%
0.00%
+50.0%
Q1 2014$1,103,000
+2.6%
14,632
+3.0%
0.00%0.0%
Q4 2013$1,075,000
-12.0%
14,212
+3.7%
0.00%0.0%
Q3 2013$1,222,000
+28.6%
13,708
+5.2%
0.00%0.0%
Q2 2013$950,00013,0290.00%
Other shareholders
USANA HEALTH SCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
DENALI ADVISORS LLC 50,729$3,190,8541.33%
Cypress Capital, LLC 12,227$769,0780.25%
DGS Capital Management, LLC 6,835$429,9220.24%
PZENA INVESTMENT MANAGEMENT LLC 818,384$51,476,3540.22%
WINTON GROUP Ltd 26,950$1,695,1550.10%
Renaissance Technologies 1,211,797$76,2220.10%
Covestor Ltd 1,602$1010.09%
ACADIAN ASSET MANAGEMENT LLC 267,057$16,7780.07%
Ifrah Financial Services, Inc. 3,368$211,8470.07%
CAXTON ASSOCIATES LP 5,928$372,8710.06%
View complete list of USANA HEALTH SCIENCES INC shareholders